Skip to main content
. 2009 Mar;23(3):185–194. doi: 10.1089/apc.2008.0162

Table 3.

Examination of Structural Barriers (Currently and/or in the Past Six Months) According to HAART Medication Adherence

 
Adherence
Do you face any of the following problems that make it difficult for you to take your HIV medications? Adherent Nonadherent p valuea
Do you always have some place to sleep at night?      
 Yes 17 (50.0) 17 (50.0)  
 No 231 (63.8) 131 (36.2) 0.14
Problems with medical insurance?      
 Yes 32 (43.8) 41 (56.2)  
 No 216 (66.9) 107 (33.1) 0.0004
Problems with transportation to pick up your medicines?      
 Yes 16 (36.4) 28 (63.6)  
 No 232 (65.9) 120 (34.1) 0.0002
Problems with transportation to get to the clinic for your visit with your provider?      
 Yes 35 (47.9) 38 (52.1)  
 No 213 (65.9) 110 (34.1) 0.0049
Problems getting your medication prescriptions filled?      
 Yes 24 (47.1) 27 (52.9)  
 No 224 (64.9) 121 (35.1) 0.019
Problems related to your job or school?      
 Yes 20 (42.6) 27 (57.4)  
 No 228 (65.3) 121 (34.7) 0.0035
Problems dealing with your family or taking care of your children, either your own or someone else's children?      
 Yes 16 (35.6) 29 (64.4)  
 No 232 (66.1) 119 (33.9) 0.0001
Number of structural barriers:      
 None 152 (72.7) 57 (27.3)  
 One barrier 59 (62.1) 36 (37.9)  
 Two or more barriers 37 (40.2) 55 (59.8) < 0.0001
a

P values were obtained from Fisher's exact test examining the association of structural barriers with adherence.

HAART, highly active antiretroviral therapy.